AVP and chronic obstructive pulmonary disease: Copeptin levels have been recently shown to correlate with outcomes in the following conditions: acute exacerbation of chronic obstructive pulmonary disease [6], ischemic stroke [7], myocardial infarction [8,14], heart failure [9,10], and even in patients presenting to the emergency department with nonspecific complaints [15].